Monday, June 18, 2018

bio technology

bio technology
The WHO headquarters are pictured in Geneva

Gap in Regulating Biotech Drug Copies Prompts WHO to Step In

By Ben Hirschler LONDON (Reuters) Cut-price copies of expensive biotech drugs promise to slash the cost of treating serious diseases, including cancer, in rich and...
Roche breast cancer drug treatment time can be halved - study

Roche Breast Cancer Drug Treatment Time Can Be Halved – Study

By Deena Beasley (Reuters) Treating early stage breast cancer patients for just six months with Roche's Herceptin works as well as the current 12-month regimen, researchers...
Medigene in for up to $1.5 billion under broader pact with Bluebird Bio

Medigene in for Up to $1.5 Billion under Broader Pact with...

t-ceBy Ludwig Burger FRANKFURT (Reuters) German biotech firm Medigene has secured a wider remit under a collaboration with U.S. peer Bluebird Bio on a technology...
Bill Gates speaks during an interview with Reuters in London

Gates Backs Gene Technologies in Fight to End Malaria

By Kate Kelland LONDON, April 18 (Reuters) Gene-editing technologies that alter mosquitoes' DNA could prove critical in the fight against malaria, Bill Gates said on...
The ticker and logo for General Electric Co. is displayed on a screen at the post where it's traded on the floor of the NYSE

GE Rides Gene Therapy Wave with Ready-Made Viral Drug Factories

By Ben Hirschler LONDON (Reuters) General Electric is raising its bet on biotechnology with the launch of prefabricated manufacturing units for producing virus-based gene and cell...
Swiss pharmaceutical group Lonza's world’s largest dedicated cell and gene therapy facility in Houston

Lonza’s Virus Factory Shows Gene Therapy’s Texas-Sized Promise

By John Miller ZURICH (Reuters) Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative...
banner